Página 2 - Melhores Fibromas uterinos médicos - TOP-159 médicos

Dr. Alper Eraslan is an experienced Obstetrics and Gynaecology Surgeon. He is also a certified IVF Specialist. Since 2019, he has been practicing at Dunya IVF. Before this, he worked at Koc University Hospital in Istanbul. He received his IVF certification from the American Hospital in Istanbul.

Dr. Eraslan earned his medical degree from Dokuz Eylul University. He completed his residency in Obstetrics and Gynaecology at Marmara University Hospital. He received ESGO fellowships at Klinikum Frankfurt Höchst in Germany and UZ Leuven in Belgium. He also holds a Master’s in Clinical Studies from the University of London and the London School of Hygiene and Tropical Medicine.

Dr Seree Teerapong, M.D.

OBSTETRICIAN AND GYNECOLOGIST (IN–VITRO FERTILIZATION: IVF)

Graduation (M.D. From)

Bachelor of Medicine, Faculty of Medicine, Chiang Mai University

Certificates

1. Diploma in Obstetrics and Gynecology, Faculty of Medicine, Siriraj Hospital, Mahidol University
2.  
3. Diploma in Reproductive Medicine, Medical Council of Thailand
4. Certificate in Laparoscopic Gynecological Surgery, Medical Council of Thailand

Current Positions

Obstetrician and gynecologist (IN-VITRO FERTILIZATION: IVF) at Intrarat Hospital

Educational Background & Certifications

Dr. Tanut graduated with **First-Class Honors** from **Mahidol University (Siriraj Hospital)** in 2010, one of Thailand’s top medical institutions. He then specialized in **Obstetrics and Gynecology (OB&GYN)** and pursued further training in **Reproductive Medicine** at **Chiang Mai University**, earning his board certifications in 2015 and 2017.

In addition, he has completed several specialized training programs, including:

- 2017: Cytogenetics Training, Human Genetic Laboratory, Ramathibodi Hospital, Thailand

- 2017: Phramongkutklao Menopause Preceptorship Program, Bangkok, Thailand

- 2018: Embryo Biopsy & Blastocyst Vitrification Workshop, ATE Training Center, Chiang Mai, Thailand

Professional Experience

Dr. Tanut has worked at leading hospitals and fertility centers, gaining hands-on experience in **assisted reproductive technology (ART):

• 2016 - 2017: Maharaj Nakorn Chiangmai Hospital, Lanna Hospital, Chiangmai Ram Hospital
• 2017 - 2018: Phyathai Sriracha Hospital** – Served as Medical Director, leading fertility programs and contributing to international accreditation standards.
• 2018 - 2020: First Fertility PGS Centre Bangkok – Played a key role in achieving Joint Commission International (JCI) Accreditation, ensuring the center met world-class fertility treatment standards.
• 2020 - 2021:CHG Hospital Group, Center for Advanced Reproductive Medicine
  2020 - present : Bangkok Central Clinic, Medical Director

Currently, he serves as the Medical Director at Bangkok Central Clinic (BCC IVF & Wellness), where he oversees patient care, treatment innovation, and the development of advanced fertility solutions.

Global Expertise & International Recognition

Dr. Tanut is actively engaged in global reproductive medicine research and training, frequently participating in international conferences and knowledge exchanges:

- 2018:

• 8th Asia Pacific Initiative on Reproduction (ASPIRE), Taiwan
• 34th European Society of Human Reproduction and Embryology (ESHRE), Spain

- 2019:

• 9th ASPIRE Congress, Hong Kong
• 35th ESHRE Annual Meeting, Austria
• Fertility Society of Australia Annual Conference, Australia
• Invited Speaker on Reproductive Technology at Anhui Provincial Hospital, China

Head of the Department of Gynecology and Breast Cancer Center

Departamento de Ginecologia

• Formação/Carreira Acadêmica
• Graduado pela Universidade da Califórnia, Berkeley
• Graduado pela Faculdade de Medicina da Universidade da Coreia
• Concluiu estágio no Centro Médico da Universidade da Coreia
• Residente em Obstetrícia e Ginecologia no Centro Médico da Universidade da Coreia
• Instrutor Clínico no Hospital Guro da Universidade da Coreia
• Professor Clínico Assistente (Adjunto) no Hospital Guro da Universidade da Coreia
• Filiações profissionais
• Membro Efetivo da Sociedade Coreana de Obstetrícia e Ginecologia
• Membro Efetivo da Sociedade Coreana de Endocrinologia Obstétrica
• Membro Efetivo da Sociedade Coreana de Endoscopia Ginecológica
• Membro Efetivo da Sociedade Coreana de Menopausa
• Membro Vitalício da Sociedade Coreana para Pesquisa Óssea e Mineral

Especialidades

Ginecologia geral, cirurgia laparoscópica, cirurgia robótica, diagnóstico e manejo da menopausa/osteoporose, clínica para mulheres solteiras, distúrbios menstruais e de ovulação, diagnóstico precoce e manejo de condições ginecológicas, consulta para pacientes estrangeiros

• MSc in Prenatal Genetic and Fetal Medicine from University College London, UK
• Sub-specialist Training in Maternal Fetal Medicine at the University of Barcelona, Spain
• Certified in Fetal Scanning by FMF at King’s College London, UK.
• CCT (Certificate of Completion of Training) from Ruhr University Bochum, Germany
• Gyne Aesthetics Diploma at American aesthetic association college
•  
• Expert Leadership:
• High-risk Pregnancies
• Obstetrics & Fetal Anomaly
  Diagnostics
  Multiple Pregnancies
  Aesthetic gynecology

Education:

• 2022: Fellowship in Reproductive Medicine, Chulalongkorn University

• 2020: Residency in Obstetrics and Gynaecology, Chiang Mai University

• 2016: Doctor of Medicine, Navamindradhiraj University (1st class honor)

Work Experience:

• Reproductive Medicine Specialist at Chulabhorn Hospital, Chulabhorn Royal Academy


Academic Work:

• Won first-place research award with the research title: The effect of combined hormonal contraceptives usage on bone turnover markers: a systematic review and meta-analysis

• The best research presentation award provided by Thai Osteoporosis Foundation

Dr. Sevinc Serdarli is a specialist in gynecology and obstetrics with 11 years of experience. She focuses on in vitro fertilization, intrauterine insemination, gynecological ultrasound, colposcopy, and advanced gynecological surgeries.

She graduated from Azerbaijan Medical University. She completed her specialization at Health Sciences University in Istanbul. Dr. Serdarli has published research on tumor markers, psychological screening in childbirth, and diagnostics in pelvic inflammatory disease.

She is a member of the Turkish Medical Association and the Istanbul Medical Chamber. She has also completed accredited courses in laparoscopy, ovulation induction, and IVF.

Education & Expertise

2003 | Ankara University Faculty of Medicine – Medical Degree

2009 | Ankara University Faculty of Medicine – Specialization in Gynecology and Obstetrics

2016 | Ankara Etlik Zübeyde Hanım Gynecology Training and Research Hospital – Gynecological Oncology Surgery

2016 | Ankara Etlik Zübeyde Hanım Gynecology Training and Research Hospital – Specialization in Gynecology and Obstetrics

Professional Experience

2003 to 2009 | Ankara University Faculty of Medicine – Medical Doctor & Specialization Training

2009 to 2016 | Ankara Etlik Zübeyde Hanım Gynecology Training and Research Hospital – Specialist in Gynecology and Obstetrics

2016 to  Present | Gynecological Oncology Surgeon & Specialist in Gynecology and Obstetrics

Professional Memberships

-Turkish Medical Association – Ankara Medical Chamber

-Turkish Gynecology and Obstetrics Association

-Turkish Gynecological Oncology Association

-Gynecological Endoscopy Association

Courses & Certifications

Clinical Observer | Northern Gynaecological Oncology Centre, Gateshead, UK – 2014

Clinical Observer | Barts Health NHS Trust Cancer Clinical Academic Unit, London, UK – 2014 (Two Months)

Dr. Yavuz Aydin is a Professor of Obstetrics and Gynecology. He currently practices at Istanbul Aydın University VM Medical Park Florya Hospital. He earned his medical degree from Hacettepe University. He completed his specialty training in Obstetrics and Gynecology at Istanbul University Cerrahpaşa Faculty of Medicine. He later became an associate professor and then a professor at the same institution.

Dr. Aydin has broad experience in both academic and private hospitals. He has held leadership positions at Biruni University and Private Medicana Hospital. He is an active member of professional organizations such as TJOD, TSRM, ASRM, and ESHRE.

His main areas of expertise include in vitro fertilization (IVF), intrauterine insemination (IUI), laparoscopic and hysteroscopic surgeries, and microsurgical tuboplasty.

Professor, Head of the Department of Obstetrics and Gynecology. Oncogynecologist.

HEESEOK KANGDepartment of Obstetrics

• Education/Academic career
• Graduated from Yonsei University College of Medicine
• Internship, Samsung Medical Center
• Residency and M.D., Obstetrics and Gynecology, Samsung Medical Center
• Head of Department, Obstetrics and Gynecology, Gyeonggi Provincial Medical Center Pocheon Hospital
• Clinical Instructor, Obstetrics and Gynecology, Samsung Medical Center
• Head of Department, Obstetrics and Gynecology I, Good Morning Hospital
• Head of Department, Obstetrics and Gynecology, Daerim St. Mary’s Hospital
• Director of Obstetrics and Gynecology & Academic Affairs of Medical Department , Hismedi Hospital
• Head of Department, Heryoujae Women’s Hospital
• Current)Adjunct Professor, Obstetrics and Gynecology, Samsung Medical Center
• Current)Expert for NAVER KnowledgeiN
• Professional memberships
• Award for Exemplary Safety Management, Samsung Medical Center, 2002
• Award for Excellence in QI Poster, Samsung Medical Center, 2007
• Outstanding Thesis Award, Korean Society of Gynecologic Oncology and Colposcopy, 2008
•  
• [Thesis]
•  
• 1. Single port access laparoscopic adnexal surgery. Kim TJ, Lee YY, Kim MJ, Kim CJ, Kang H, Choi CH, Lee JW, Kim BG, Bae DS. J Minim Invasive Gynecol. 2009 SepOct;16(5):6125.
• 2. The prognostic significance of the SUVmax (maximum standardized uptake value for F18 fluorodeoxyglucose) of the cervical tumor in PET imaging for early cervical cancer: preliminary results. Lee YY, Choi CH, Kim CJ, Kang H, Kim TJ, Lee JW, Lee JH, Bae DS, Kim BG. Gynecol Oncol. 2009 Oct;115(1):658. Epub 2009 Jul 15.
• 3. Singleport access laparoscopicassisted vaginal hysterectomy: a novel method with a wound retractor and a glove. Lee YY, Kim TJ, Kim CJ, Kang H, Choi CH, Lee JW, Kim BG, Lee JH, Bae DS. J Minim Invasive Gynecol. 2009 JulAug;16(4):4503. Epub 2009 May 31.
• 4. Topotecan combined with carboplatin in recurrent epithelial ovarian cancer: results of a singleinstitutional phase II study. Kang H, Kim TJ, Lee YY, Choi CH, Lee JW, Bae DS, Kim BG. Gynecol Oncol. 2009 Aug;114(2):2104. Epub 2009 May 14.
• 5. MR Imaging in Endometrial Carcinoma as a Diagnostic Tool for the Prediction of Myometrial Invasion and Lymph Node Metastasis. Ryoo UN, Choi CH, Yoon JY, Noh SK, Kang H, Kim WY, Kim BH, Kim TJ, Lee JW, Lee JH, Kim BG, Bae DS. Cancer Res Treat. 2007 Dec;39(4):16570. Epub 2007 Dec 31.
• 6. Prognostic value of baseline lymphocyte count in cervical carcinoma treated with concurrent chemoradiation. Choi CH, Kang H, Kim WY, Kim TJ, Lee JW, Huh SJ, Lee JH, Kim BG, Bae DS. Int J Radiat Oncol Biol Phys. 2008 May 1;71(1):199204.
• 7. Lowgrade endometrial stromal sarcoma: a single center's experience with 22 cases. Kim WY, Lee JW, Choi CH, Kang H, Kim TJ, Kim BG, Lee JH, Bae DS. Int J Gynecol Cancer. 2008 SepOct;18(5):10849.
• 8. Outcome and reproductive function after cumulative highdose combination chemotherapy with bleomycin, etoposide and cisplatin (BEP) for patients with ovarian endodermal sinus tumor. Kang H, Kim TJ, Kim WY, Choi CH, Lee JW, Kim BG, Bae DS. Gynecol Oncol. 2008 Oct;111(1):10610.
• 9. Prognostic significance of VEGF expression in patients with bulky cervical carcinoma undergoing neoadjuvant chemotherapy. Choi CH, Song SY, Choi JJ, Park YA, Kang H, Kim TJ, Lee JW, Kim BG, Lee JH, Bae DS. BMC Cancer. 2008 Oct 11;8:295.
• 10. Phase II Study of Combination Chemotherapy with Etoposide and Ifosfamide in Patients with Heavily Pretreated Recurrent or Persistent Epithelial Ovarian Cancer Kang H, Kim TJ, Choi CH, Lee JW, Lee JH, Bae DS, Kim BG. JKMS. 2009 Oct. (in press)
• 11. Ritodrine hydrochloride 단독 투여와 magnesium sulfate와의 병합 투여의 조기진통 억제효과 및 안정성에 대한 비교 김영아, 강희석, 양순하, 김종화 대한산부인과학회 2002;45:1991.
• 12. Experience of Surgical Treatment for Adnexal Lesions in Adolescent Patients 이은주, 강희석, 윤병구, 배덕수, 최두석 대한산부내시경 2002;14:79
• 13. 태아간 수혈증후군이 의심되는 단일 융모막성 쌍태임신에서 발견된 일측 쌍생아의 선천성 뇌실주위 백질 연화증 1예 강희석, 양순하, 오성희, 강병희, 노정래, 김종화 대한산부인과학회 2002:45:841
• 14. 자궁근종 치료에서 modified LAM 기법의 타당성 조사 연구 이은주, 김태중, 지현영, 김하정, 김철중, 이유영, 강희석, 최철훈, 이정원, 김병기, 배덕수 대한산부내시경 2008;20:35
• 15. 위암, 유방암, 난소암의 원발성 중복암이 있었던 환자의 증례보고 최현진, 최철훈, 김태중, 강희석, 이은주, 이정원, 김병기, 이제호, 배덕수 대한산부인과학회 2008;51:1519
• 16. Factors associated with complicationsand conversion to laparotomy in women undergoing laparoscopically assistedvaginal hysterectomy. Song T, Kim TJ, Kang H, Lee YY, Choi CH, Lee JW, Kim BG, Bae DS. Acta Obstet Gynecol Scand. 2012 May;91(5):6204.
• 17. A review of the technique and complicationsfrom 2,012 cases of laparoscopically assisted vaginal hysterectomy at a singleinstitution. Song T, Kim TJ, Kang H, Lee YY, Choi CH, Lee JW, Kim BG, Bae DS. Aust N Z J Obstet Gynaecol. 2011 Jun;51(3):23943.
• 18. The use of misoprostol beforehysteroscopic surgery in nonpregnant premenopausal women: a randomizedcomparison of sublingual, oral and vaginal administrations. Lee YY, Kim TJ, Kang H, Choi CH, Lee JW, Kim BG, Bae DS. Hum Reprod. 2010 Aug;25(8):19428.
• 19. Prognostic significance of pSTAT3 inpatients with bulky cervical carcinoma undergoing neoadjuvant chemotherapy. Choi CH, Song SY, Kang H, Lee YY, Kim CJ, Lee JW, Kim TJ, Kim BG, Lee JH, Bae DS. J Obstet Gynaecol Res. 2010 Apr;36(2):30410.
• 20. Outcome and reproductive function after cumulative highdose combination chemotherapy with bleomycin, etoposideand cisplatin (BEP) for patients with ovarian endodermal sinus tumor. Kang H, Kim TJ, Kim WY, Choi CH, Lee JW, Kim BG, Bae DS.

Professor Massimo Candiani is a renowned gynecologist with over 30 years of experience and a specialist in endoscopic and laparoscopic surgeries, treatment of endometriosis, ovarian cysts, infertility, sexually transmitted diseases and urinary incontinence. He is also a co-founder and vice president of the Italian Endometriosis Association and a member of several professional organizations.

Dr. Gulcan Albayrak is a gynecology and women’s health specialist. She trained at Uludağ University Faculty of Medicine, Ankara Zekai Tahir Burak Women’s Health Training and Research Hospital, and the Harris Birthright Fetal Medicine Research Center in London. She has worked at Medicine Hospital, Private İlke Hospital, Private GOP Hospital, Ankara Çankaya Özel Hasvak Hospital, and Erzincan State Hospital. She also served as a specialist at Medcare Hospital, Dubai.

Her advanced training includes hysteroscopy (Sunrise Hospital, Kerala) and colposcopy (Istanbul University–Çapa). She also trained in non-hormonal menopause care (Exeltis, Madrid), MonaLisa Touch CO2 vaginal laser, genital aesthetics (ICC), and vulvar filler/PRP. She holds a Ministry of Health–approved mesotherapy certificate. She is a member of TJOD, TSRM, the Turkish-German Gynecology Association, EJD, ITO, and ESAG. Publications include “Reproductive outcome of septate uterus after hysteroscopic metroplasty” (Archives of Gynecology & Obstetrics, Vol. 26B, Issue 4, Oct 2003, ZaS-ZSZI) and a cervical rhabdomyosarcoma case report (poster, Antalya Congress).